CY1110444T1 - Μεθοδοι μετατροπης ισομορφων των ιντερφερονων και προϊοντων τους - Google Patents

Μεθοδοι μετατροπης ισομορφων των ιντερφερονων και προϊοντων τους

Info

Publication number
CY1110444T1
CY1110444T1 CY20081101455T CY081101455T CY1110444T1 CY 1110444 T1 CY1110444 T1 CY 1110444T1 CY 20081101455 T CY20081101455 T CY 20081101455T CY 081101455 T CY081101455 T CY 081101455T CY 1110444 T1 CY1110444 T1 CY 1110444T1
Authority
CY
Cyprus
Prior art keywords
converting
present
interference
products
methods
Prior art date
Application number
CY20081101455T
Other languages
English (en)
Inventor
Susan Cannon-Carlson
Andres Frei
Seoju Lee
Roland Mengisen
Marcio Voloch
David C Wylie
Original Assignee
Schering Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corporation filed Critical Schering Corporation
Publication of CY1110444T1 publication Critical patent/CY1110444T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/56—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Η παρούσα εφεύρεση παρέχει μεθόδους για απομόνωση παρεπόμενων ισόμορφων πρωτεΐνης και μετατροπή τους στην επιθυμούμενη πρωτεΐνη. Σε προτιμούμενες πραγματοποιήσεις, η παρούσα εφεύρεση εξετάζει τη χρήση όξινων διαλυμάτων ή διαλυμάτων ψευδαργύρου για σχάση μιας χημικής ομάδας από την επιθυμούμενη πρωτεΐνη. Σε περαιτέρω προτιμούμενες πραγματοποιήσεις, η παρούσα εφεύρεση εξετάζει την οξείδωση αναγμένων σουλφυδρυλομάδων με σχάση χημικών ομάδων για να σχηματιστεί η λειτουργική επιθυμούμενη πρωτεΐνη.
CY20081101455T 1998-11-12 2008-12-16 Μεθοδοι μετατροπης ισομορφων των ιντερφερονων και προϊοντων τους CY1110444T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19054298A 1998-11-12 1998-11-12
EP99951431A EP1129111B1 (en) 1998-11-12 1999-10-05 Methods for conversion of interferon isoforms and products thereof

Publications (1)

Publication Number Publication Date
CY1110444T1 true CY1110444T1 (el) 2015-04-29

Family

ID=22701766

Family Applications (2)

Application Number Title Priority Date Filing Date
CY20081101455T CY1110444T1 (el) 1998-11-12 2008-12-16 Μεθοδοι μετατροπης ισομορφων των ιντερφερονων και προϊοντων τους
CY20101100841T CY1110794T1 (el) 1998-11-12 2010-09-16 Μεθοδοι μετατροπης ισομορφων ιντερφερονης και προϊοντων της

Family Applications After (1)

Application Number Title Priority Date Filing Date
CY20101100841T CY1110794T1 (el) 1998-11-12 2010-09-16 Μεθοδοι μετατροπης ισομορφων ιντερφερονης και προϊοντων της

Country Status (27)

Country Link
EP (2) EP1894944B1 (el)
JP (3) JP4468585B2 (el)
KR (1) KR100922454B1 (el)
CN (2) CN101255188A (el)
AR (1) AR023906A1 (el)
AT (2) ATE409706T1 (el)
AU (1) AU766309B2 (el)
BR (1) BR9915257A (el)
CA (1) CA2348739C (el)
CY (2) CY1110444T1 (el)
CZ (2) CZ302402B6 (el)
DE (2) DE69942655D1 (el)
DK (2) DK1129111T3 (el)
ES (2) ES2348104T3 (el)
HK (2) HK1035544A1 (el)
HU (1) HU228265B1 (el)
ID (1) ID28552A (el)
IL (2) IL142546A0 (el)
NO (2) NO329483B1 (el)
NZ (1) NZ511074A (el)
PL (2) PL200274B1 (el)
PT (2) PT1129111E (el)
SI (2) SI1894944T1 (el)
SK (2) SK287564B6 (el)
TW (1) TW577894B (el)
WO (1) WO2000029440A1 (el)
ZA (1) ZA200103010B (el)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU228265B1 (en) * 1998-11-12 2013-02-28 Merck Sharp & Dohme Methods of conversion of interferon isoforms and products thereof
SG172386A1 (en) * 2008-12-23 2011-08-29 Schering Corp Purification of recombinantly produced interferon
EP4139343A4 (en) * 2020-04-20 2024-06-12 National Research Council of Canada RECOMBINANT INTERFERON

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO164037C (no) 1980-01-08 1990-08-22 Biogen Inc Fremgangsmaate ved fremstilling av et polypeptid av interferon alfa (ifnalfa)-type.
US4530901A (en) 1980-01-08 1985-07-23 Biogen N.V. Recombinant DNA molecules and their use in producing human interferon-like polypeptides
US4315852A (en) 1980-11-26 1982-02-16 Schering Corporation Extraction of interferon from bacteria
US4364863A (en) * 1980-12-29 1982-12-21 Schering Corporation Extraction of interferon from bacteria
EP0082481B2 (en) 1981-12-23 1990-09-12 Schering Corporation Stabilised alpha-interferon formulations and their preparation
DE3515336C2 (de) * 1985-04-27 1994-01-20 Boehringer Ingelheim Int Verfahren zur Herstellung und Reinigung von â-Interferon
US4847079A (en) 1985-07-29 1989-07-11 Schering Corporation Biologically stable interferon compositions comprising thimerosal
US4732683A (en) 1986-12-02 1988-03-22 Biospectrum, Inc. Purification method for alpha interferon
US4765903A (en) 1987-10-06 1988-08-23 Interferon Sciences, Inc. Purification of monomeric interferon
US5272135A (en) 1991-03-01 1993-12-21 Chiron Ophthalmics, Inc. Method for the stabilization of methionine-containing polypeptides
AU648214B2 (en) * 1991-12-31 1994-04-14 Lucky Limited Recombinant gene coding for human alpha interferon and expression vector thereof, etc.
ES2161793T3 (es) * 1994-04-09 2001-12-16 Hoffmann La Roche Proceso para la produccion de alfa-interferona.
US5766582A (en) 1994-10-11 1998-06-16 Schering Corporation Stable, aqueous alfa interferon solution formulations
HU228265B1 (en) * 1998-11-12 2013-02-28 Merck Sharp & Dohme Methods of conversion of interferon isoforms and products thereof

Also Published As

Publication number Publication date
WO2000029440A1 (en) 2000-05-25
CA2348739A1 (en) 2000-05-25
SI1129111T1 (sl) 2009-06-30
PT1129111E (pt) 2008-12-22
CZ303110B6 (cs) 2012-04-04
EP1894944A1 (en) 2008-03-05
CN101255188A (zh) 2008-09-03
ATE476445T1 (de) 2010-08-15
PL200274B1 (pl) 2008-12-31
ATE409706T1 (de) 2008-10-15
IL142546A (en) 2013-07-31
JP2002530291A (ja) 2002-09-17
SK287564B6 (sk) 2011-02-04
NO20100775L (no) 2001-05-11
NO329483B1 (no) 2010-10-25
AU766309B2 (en) 2003-10-16
SK287372B6 (sk) 2010-08-09
PL201341B1 (pl) 2009-04-30
ES2348104T3 (es) 2010-11-30
ZA200103010B (en) 2002-07-11
SK6172001A3 (en) 2001-10-08
DK1129111T3 (da) 2009-01-05
HU228265B1 (en) 2013-02-28
EP1129111A1 (en) 2001-09-05
KR100922454B1 (ko) 2009-10-21
IL142546A0 (en) 2002-03-10
DE69939657D1 (de) 2008-11-13
JP2006348056A (ja) 2006-12-28
ES2315019T3 (es) 2009-03-16
PL348162A1 (en) 2002-05-06
EP1129111B1 (en) 2008-10-01
AU6387099A (en) 2000-06-05
JP4468585B2 (ja) 2010-05-26
NO20012327L (no) 2001-05-11
DE69942655D1 (de) 2010-09-16
DK1894944T3 (da) 2010-10-18
AR023906A1 (es) 2002-09-04
BR9915257A (pt) 2001-08-07
CN100390197C (zh) 2008-05-28
KR20010080336A (ko) 2001-08-22
CZ20011303A3 (cs) 2001-08-15
SI1894944T1 (sl) 2010-11-30
PT1894944E (pt) 2010-10-28
NO331699B1 (no) 2012-02-27
CZ302402B6 (cs) 2011-05-04
CN1326465A (zh) 2001-12-12
HUP0104113A3 (en) 2004-04-28
NZ511074A (en) 2003-10-31
CY1110794T1 (el) 2015-06-10
ID28552A (id) 2001-05-31
EP1894944B1 (en) 2010-08-04
JP2010209117A (ja) 2010-09-24
HUP0104113A2 (hu) 2002-03-28
HK1112746A1 (en) 2008-09-12
NO20012327D0 (no) 2001-05-11
CA2348739C (en) 2010-05-11
TW577894B (en) 2004-03-01
HK1035544A1 (en) 2001-11-30

Similar Documents

Publication Publication Date Title
CY1105836T1 (el) 12, 13-τροποποιημενα παραγωγα εποθιλονης
CY1117551T1 (el) Μεθοδος ελεγχου της δραστικοτητας ανοσολογικα λειτουργικου μοριου
CY1111042T1 (el) Μεθοδος απομονωσης βλαστικων κυτταρων
DE69736669D1 (de) Zelladhäsionsinhibitoren
CY1106722T1 (el) Περικαλυμμενη τσικλα
DE69633679D1 (de) Substituierte aryl-oder heteroarylamide mit retinoid-ähnlicher biologischer aktivität
FI114422B (fi) Lähteen puheaktiviteetin tunnistus
CY1106992T1 (el) Καχαλαλιδη f και συναφεις ενωσεις
TR200000782T2 (tr) Resorsinol türevleri.
ES2177810T3 (es) Lamina recubierta de aerogel.
DE69918089D1 (de) Btk inhibitoren und verfahren zur identifizierung und verwendung
ATE268379T1 (de) Enzym mit aminopeptidaseactivität
EA200300464A1 (ru) ГУМАНИЗИРОВАННОЕ АНТИТЕЛО ПРОТИВ РЕЦЕПТОРА ЛИМФОТОКСИНА-β (ВАРИАНТЫ), КОМПОЗИЦИЯ, СПОСОБ ЛЕЧЕНИЯ ИЛИ СНИЖЕНИЯ РИСКА РАЗВИТИЯ, ТЯЖЕСТИ ИЛИ ПОСЛЕДСТВИЙ НЕОПЛАЗИИ У ЧЕЛОВЕКА, ВЫДЕЛЕННАЯ НУКЛЕИНОВАЯ КИСЛОТА (ВАРИАНТЫ), КЛЕТКА КЛЕТОЧНОЙ ЛИНИИ
TR200401348T4 (tr) Yapay elyaf halatların kontrol edilmesi için elektrik kontağı
DE69720822D1 (de) Verwendung von Sprachaktivitätserkennung zur effizienten Sprachkodierung
DE69630955T2 (de) Immortalisierung bzw. desimmortalisierung von zellen
CY1110444T1 (el) Μεθοδοι μετατροπης ισομορφων των ιντερφερονων και προϊοντων τους
ES2186807T3 (es) Inhibidores de trombina.
DE69915690D1 (de) Antikonvulsive derivate zur behandlung von posttraumatischen stresserkrankungen
ES2179908T3 (es) Acidos sacarosamonocarboxilicos acilados.
ATE307201T1 (de) Srcr domäne-enthaltendes protein
ATE309371T1 (de) Protein mit dnase-aktivität
ATE238791T1 (de) Verwendung von 2-methyl-thiazolidin-2,4- dicarbonsäure als mukolytikum
ATE222103T1 (de) Inklusionskomplexe in waessriger loesung
GR930100340A (el) Μέ?οδος για την καταπολέμηση εντόμων.